The main objective of this study is to identify risk factors for depression among medical students by comparing them to students who completed their first year but did not enter the medical program (students not accepted into the second year of medical school).
Major Depressive Disorder (MDD) will be assessed using a validated tool: the Composite International Diagnostic Interview Short-Form (CIDI-SF).
This a prospective, longitudinal, cohort study. The plan is to inform each new cohort of students at the Orléans University Hospital medical school for 10 years. It is estimated that 5,000 to 10,000 students will be able to participate in the study.
A link to access the study questionnaire will be sent to students by email via the registrar's office, with one email per week for four weeks. The email will contain a link to a web page where the questionnaire can be completed. The questionnaire will be available online on computers or smartphones for six weeks: from mid-October to the end of November. The questionnaire will be completed each year for the duration of the study or until the student completes their studies.
Duration of the inclusion period: 10 years Duration of participation for each participant: maximum 12 years Total duration of the study: 22 years As the cohort progresses, longitudinal analyses may be conducted to study the evolution of various disorders over time, adjusting for known confounding factors. Following the initial analyses of this study, a new interventional study will be set up to identify students at risk and offer them appropriate care.
Students who have been enrolled in first year of health studies at the University of Orléans
Aged 18 or over
Does not speak French
Person under legal guardianship
Person deprived of liberty
Person under guardianship or trusteeship
All students who were enrolled in their first year of health studies at the University of Orléans
Cohort
Prospective
Questionnaire
Other interventionQuestionnaire to be completed once a year
Measure Major Depressive Disorder prevalence
Measure of the 12-month Major Depressive Disorder prevalence by the Composite International Diagnostic Interview Short-Form (CIDI-SF).
Measure prevalence of psychiatric disorders
Measure the annual prevalence of psychiatric disorders other than depression (anxiety, burnout, eating disorders, alcohol and cannabis addiction, childhood trauma) among medical students by comparing them to students who completed their first year but did not enter the medical. Anxiety will be assessed using the GAD7; eating disorders by the SCOFF, alcohol addiction by the AUDIT, cannabis addiction by the CUDIT, burnout by the MBI-SS (student version for pre-clinical students) or the MBI-HSS (caregiver version for externs and residents), and childhood trauma by the ACE.
Identify risk and protective factors for psychiatric disorders
Identify risk and protective factors for psychiatric disorders other than depression (anxiety, burnout, eating disorders, alcohol and cannabis addiction) among medical students by comparing them to students who completed their first year but did not enter the medical program. Anxiety will be assessed using the GAD7; eating disorders by the SCOFF, alcohol addiction by the AUDIT, cannabis addiction by the CUDIT, burnout by the MBI-SS (student version for pre-clinical students) or the MBI-HSS (caregiver version for externs and residents), and childhood trauma by the ACE.
Measure Major Depressive Disorder prevalence by year
Measure the prevalence of major depressive disorder each year among medical students by comparing them to students who have completed their first year but have not entered the medical program. Major Depressive Disorder prevalence will be measure by the Composite International Diagnostic Interview Short-Form (CIDI-SF).
Measure the prevalence of healthcare use and non-use
Measure the prevalence of healthcare use and non-use among medical students each year by comparing them to students who completed their first year but did not enter the medical program. Healthcare use will be assessed using questions from the WHO quality of life questionnaire, the Observatoire de la Vie Etudiants questionnaires, and the Mental Ill-ness : Clinicians' Attitudes (MICA).
Click on the lead sponsor to view all of their trials.
